Please ensure Javascript is enabled for purposes of website accessibility
Skip to main content
Poised to address unmet need in neuromuscular diseases and
positioned for growth

SEC Filing

SEC Filing Details

Document Details

Form
Filing Date
Jun 23, 2026
Document Date
Jun 22, 2026
Form Description
Initial filing by director officer or owner of more than ten percent
Filing Group
3,4,5
Company
Dyne Therapeutics, Inc.
Issuer
DYNE THERAPEUTICS, INC.
Filer
Greene Barry E